The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3
Authors
Keywords
Kidney, Renal fibrosis, PPARγ, TGF-β, Transcription factors
Journal
BMC Nephrology
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-05
DOI
10.1186/s12882-019-1431-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
- (2018) Michael J Curtis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Sustained hyperosmolarity increses TGF-ß1 and Egr-1 expression in the rat renal medulla
- (2017) Miklós M. Mózes et al. BMC Nephrology
- Cinaciguat ameliorates glomerular damage by reducing ERK1/2 activity and TGF-ß expression in type-1 diabetic rats
- (2017) Szabina Czirok et al. Scientific Reports
- Peroxisome proliferator-activated receptor-γ agonist pioglitazone fails to attenuate renal fibrosis caused by unilateral ureteral obstruction in mice
- (2016) Ying Zhang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thiazolidinediones and the Promise of Insulin Sensitization in Type 2 Diabetes
- (2014) Raymond E. Soccio et al. Cell Metabolism
- Risk factors for chronic kidney disease: an update
- (2013) Rumeyza Kazancioğlu Kidney International Supplements
- Egr-1: new conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis)
- (2012) Swati Bhattacharyya et al. JOURNAL OF PATHOLOGY
- The role of the Janus kinase family/signal transducer and activator of transcription signaling pathway in fibrotic renal disease
- (2012) Futoshi Matsui et al. JOURNAL OF SURGICAL RESEARCH
- PPARγ as a therapeutic target in diabetic nephropathy and other renal diseases
- (2011) Jichun Yang et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Lipocalin 2 is essential for chronic kidney disease progression in mice and humans
- (2010) Amandine Viau et al. JOURNAL OF CLINICAL INVESTIGATION
- A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy
- (2010) Maoyin Pang et al. KIDNEY INTERNATIONAL
- Rosiglitazone Abrogates Bleomycin-Induced Scleroderma and Blocks Profibrotic Responses Through Peroxisome Proliferator-Activated Receptor-γ
- (2009) Minghua Wu et al. AMERICAN JOURNAL OF PATHOLOGY
- Collagen Structure and Stability
- (2009) Matthew D. Shoulders et al. Annual Review of Biochemistry
- Expression of JAKs/STATs pathway molecules in rat model of rapid focal segmental glomerulosclerosis
- (2009) Yaojun Liang et al. PEDIATRIC NEPHROLOGY
- PPAR-γ agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-β
- (2008) Toru Kawai et al. LABORATORY INVESTIGATION
- Cellular and molecular mechanisms of fibrosis
- (2007) TA Wynn JOURNAL OF PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now